Prospector
Profile
1017-03
|
| |
| VisualMed Clinical Solutions, Inc. |
NAICS |
511210 |
| 1035 Laurier St. West, Suite 200
Montreal, Quebec, Canada H2V 2L1 |
Description |
Software Publishers |
| (514) 274-1115 |
Employees |
14 |
| http://www.visualmedsolutions.com/ |
Revenue |
(mil) |
0.3550 |
| |
Income |
(mil) |
-14.6920 |
| |
Assets |
(mil) |
0.4670 |
| |
Liability |
(mil) |
1.9280 |
| |
(for the year ended 2007-06-30) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
Manning Elliott LLP raised doubts on the ability of VisualMed Clinical Solutions, Inc. to continue as a going concern after auditing its financial statements. The auditor points out that the Company had a working capital deficiency of $1,511,763 and has incurred losses of $28,474,437 since inception. The Company incurred losses of $14,692,602 for fiscal 2007 as compared to losses of $7,079,106 in fiscal 2006.
|
| |
|
Intellectual Property:
The Company does not have any patents on its system or modules. The Company relies on trade secrets laws, confidentiality agreements and other contractual commitments to protect proprietary research and development efforts and intellectual property. [SEC Filing 10-KSB 09-28-07]
|
| |
|
Description:
The Company offers the VisualMED system, a suite of software modules that constitute a comprehensive, state of the art, fully functional Clinical Information System.
|
| |
|
Officers:
Gerard Dab (CEO, Sec. & Dir.); Arthur Gelston (Pres., Chief Science Officer & Dir.); Barry Scharf (VP & COO); Larry Kurlender (CFO & Treas.); Jayne H. Kirby (VP); Michel Maksud (VP); Philippe Panzini (Dir.); Louis J. Lombardo (Dir.); Chris Marcolefas (Dir.)
|
| |
|
Auditor:
Manning Elliott LLP
|
| |
|
Securities:
Common Stock-Symbol VMCS.OB; OTC BB;
52,218,345 common shares outstanding as of September 27, 2007.
|
| |
| |
| |
| return to main page |
